Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | APX3330 |
| Trade Name | |
| Synonyms | APX-3330|APX 3330|E3330|E 3330 |
| Drug Descriptions |
APX3330 (E3330) inhibits redox factor 1 (REF1, APEX1), potentially resulting in decreased tumor angiogenesis and increased apoptosis and reduced viability, and proliferation of tumor cells (PMID: 19097035, PMID: 28446640, PMID: 31413178). |
| DrugClasses | |
| CAS Registry Number | 136164-66-4 |
| NCIT ID | C150216 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| APX3330 | APX3330 | 0 | 1 |